Pharmaspire
× About the Journal Scope of the Journal SPER Publications Editorial Board Abstracting and Indexing Articles in Press Current Issue Archives Submit Article Author Guidelines Advertise Join as Reviewer Contact Editorial Policies and Peer Review Process Journal Policies Publishing Ethics
[An Official Publication of ISF College of Pharmacy, Moga]


 

Original Article
Year : 2018   |  Volume : 10  |  Issue : 2  |  Page : 64-67

Method development and validation of mefenamic acid, dicyclomine hydrochloride, and pamabrom of marketed formulation by ultraviolet

The method has been developed and validated using the spectrophotometric technique for the simultaneous estimation of mefenamic acid (MEF), dicyclomine hydrochloride (DCL), and pamabrom (PABr) in bulk powder and in pharmaceutical formulations with a high degree of specificity, selectivity, and assurances. The first Vierdot’s method was performed and absorption maxima of MEF, DCL, and PABr at 285, 214.6, and 279 nm, respectively. Calibration graphs were established in the range of 2–10 μg/mL for MEF and PABr and 200–1000 μg/mL for DCL. Dilution was prepared in 0.1 N sodium hydroxide.
[]*
Print this article     Email this article

 

Contact SPER Publications


SPER Publications and Solutions Pvt. Ltd.

#730, Tower B, i-Thum IT Park,
Sector 62, Noida,
Uttar Pradesh 201301 [Delhi-NCR] India
Phone: +91-930-190-7999 / +91-120-410-0035
E-mail: journals@sperpublications.com
Website: www.sperpublications.com